{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:18:51Z","timestamp":1792109931618,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"DOI":"10.1007\/s11892-026-01631-8","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:51:49Z","timestamp":1782114709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness"],"prefix":"10.1007","volume":"26","author":[{"given":"Giuliana","family":"Perini Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Solorzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"1631_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.71079\/aside.im.02202517","volume-title":"Epidemiological Patterns of Diabetes Mellitus in The United States of America","author":"AY Azzam","year":"2025","unstructured":"Azzam AY, Mora LM, Morsy MM, Essibayi MA, Altschul DJ, Nassar M. Epidemiological Patterns of Diabetes Mellitus in The United States of America. Volume 1. American Society for Inclusion, Diversity, and Equity in Healthcare; 2025. p. 1. [cited 2026 Mar 12]. An Observational Multicenter Analysis From 1990 to 2024. ASIDE internal medicine [Internet]. https:\/\/doi.org\/10.71079\/aside.im.02202517"},{"key":"1631_CR2","doi-asserted-by":"publisher","unstructured":"Venkatraman S, Echouffo-Tcheugui JB, Selvin E, Fang M. Trends and disparities in glycemic control and severe hyperglycemia among US adults with diabetes using insulin, 1988-2020. JAMA Netw Open [Internet]. American Medical Association; 2022 [cited 2025 Dec 1];5:e2247656\u2013e2247656. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2022.47656.","DOI":"10.1001\/JAMANETWORKOPEN.2022.47656"},{"key":"1631_CR3","doi-asserted-by":"publisher","unstructured":"Lee W, Lloyd JT, Giuriceo K, Day T, Shrank W, Rajkumar R. Systematic review and meta-analysis of patient race\/ethnicity, socioeconomics, and quality for adult type 2 diabetes. Health Serv Res [Internet]. Blackwell Publishing Inc.; 2020 [cited 2026 Jan 14];55:741\u201372. https:\/\/doi.org\/10.1111\/1475-6773.13326;ISSUE:ISSUE:DOI.","DOI":"10.1111\/1475-6773.13326;ISSUE:ISSUE:DOI"},{"key":"1631_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/S00125-024-06107-6","volume":"67","author":"M Jancev","year":"2024","unstructured":"Jancev M, Vissers TACM, Visseren FLJ, van Bon AC, Sern\u00e9 EH, DeVries JH, et al. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia [Internet] Springer Sci Bus Media Deutschland GmbH. 2024;67:798. https:\/\/doi.org\/10.1007\/S00125-024-06107-6. [cited 2025 Feb 3];.","journal-title":"Diabetologia [Internet] Springer Sci Bus Media Deutschland GmbH"},{"key":"1631_CR5","doi-asserted-by":"publisher","unstructured":"Committee ADAPP, ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, et al. 7. Diabetes technology: standards of care in diabetes\u20142025. Diabetes Care [Internet]. American Diabetes Association; 2025 [cited 2025 Oct 5];48:S146\u201366. https:\/\/doi.org\/10.2337\/DC25-S007.","DOI":"10.2337\/DC25-S007"},{"key":"1631_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/dc22-1287","volume":"46","author":"K Ni","year":"2023","unstructured":"Ni K, Tampe CA, Sol K, Richardson DB, Pereira RI. Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes. Diabetes Care. 2023;46:391\u20138. https:\/\/doi.org\/10.2337\/dc22-1287.","journal-title":"Diabetes Care"},{"key":"1631_CR7","doi-asserted-by":"publisher","unstructured":"Seidu S, Kunutsor SK, Ajjan RA, Choudhary P. Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care [Internet]. American Diabetes Association; 2024 [cited 2026 Jan 8];47:169\u201379. https:\/\/doi.org\/10.2337\/DC23-1520.","DOI":"10.2337\/DC23-1520"},{"key":"1631_CR8","doi-asserted-by":"publisher","unstructured":"Di Molfetta S, Caruso I, Cignarelli A, Natalicchio A, Perrini S, Laviola L, et al. Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab [Internet]. John Wiley and Sons Inc; 2023 [cited 2026 Jan 8];25:1301\u201310. https:\/\/doi.org\/10.1111\/DOM.14981;SUBPAGE:STRING:FULL.","DOI":"10.1111\/DOM.14981;SUBPAGE:STRING:FULL"},{"key":"1631_CR9","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1111\/dom.70008","volume":"27","author":"R Aronson","year":"2025","unstructured":"Aronson R, Abitbol A, Bajaj HS, Cheng AYY, Christopoulos S, Harris SB, et al. Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials. Diabetes Obes Metab John Wiley Sons Inc. 2025;27:6220\u201342. https:\/\/doi.org\/10.1111\/dom.70008.","journal-title":"Diabetes Obes Metab John Wiley Sons Inc"},{"key":"1631_CR10","unstructured":"FDA Clears First Over-the-Counter Continuous Glucose Monitor [Internet]. FDA.gov. 2024 [cited 2026 Jan 6]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-over-counter-continuous-glucose-monitor. Accessed 6 Jan 2026."},{"key":"1631_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M16-2855\/SUPPL_FILE\/M16-2855_SUPPLEMENT.PDF","volume":"167","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections. Ann Intern Med [Internet] Am Coll Physicians. 2017;167:365\u201374. https:\/\/doi.org\/10.7326\/M16-2855\/SUPPL_FILE\/M16-2855_SUPPLEMENT.PDF. [cited 2022 Oct 3];.","journal-title":"Ann Intern Med [Internet] Am Coll Physicians"},{"key":"1631_CR12","doi-asserted-by":"publisher","unstructured":"Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R. Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes. JAMA [Internet]. American Medical Association; 2021 [cited 2026 Jan 8];325:2273\u201384. https:\/\/doi.org\/10.1001\/JAMA.2021.6530.","DOI":"10.1001\/JAMA.2021.6530"},{"key":"1631_CR13","doi-asserted-by":"publisher","unstructured":"Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA - J Am Med Assoc. 2021;2262\u201372. https:\/\/doi.org\/10.1001\/jama.2021.7444.","DOI":"10.1001\/jama.2021.7444"},{"key":"1631_CR14","doi-asserted-by":"publisher","unstructured":"Shields S, Thomas R, Durham J, Moran J, Clary J, Ciemins EL. Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care. Scientific Reports 2024 14:1 [Internet]. Nature Publishing Group; 2024 [cited 2026 Jan 8];14:31990. https:\/\/doi.org\/10.1038\/s41598-024-83548-4.","DOI":"10.1038\/s41598-024-83548-4"},{"key":"1631_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/dia.2023.0390","volume":"26","author":"ROM Ferreira","year":"2024","unstructured":"Ferreira ROM, Trevisan T, Pasqualotto E, Chavez MP, Marques BF, Lamounier RN, et al. Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Technol Ther. 2024;26:252\u201362. https:\/\/doi.org\/10.1089\/dia.2023.0390.","journal-title":"Diabetes Technol Ther"},{"key":"1631_CR16","doi-asserted-by":"publisher","unstructured":"Layne JE, Jepson LH, Carite AM, Parkin CG, Bergenstal RM. Long-term improvements in glycemic control with dexcom CGM use in adults with noninsulin-treated type 2 diabetes. https:\/\/home.liebertpub.com\/dia [Internet]. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA ; 2024 [cited 2026 Jan 8];26:925\u201331. https:\/\/doi.org\/10.1089\/DIA.2024.0197.","DOI":"10.1089\/DIA.2024.0197"},{"key":"1631_CR17","doi-asserted-by":"publisher","unstructured":"Polonsky WH, Soriano EC, Levrat-Guillen F, Chichmarenko M, Sandoval H, Bastian A et al. Does continuous glucose monitoring use prompt greater engagement in self-management? A randomized controlled trial focusing on adults with type 2 diabetes. J Diabetes Sci Technol [Internet]. SAGE Publications Inc.; 2025 [cited 2026 Jan 8]. https:\/\/doi.org\/10.1177\/19322968251361031;JOURNAL:JOURNAL:DSTA;PAGE:STRING:ARTICLE\/CHAPTER.","DOI":"10.1177\/19322968251361031;JOURNAL:JOURNAL:DSTA;PAGE:STRING:ARTICLE\/CHAPTER"},{"key":"1631_CR18","doi-asserted-by":"publisher","unstructured":"Al Hayek A, Klonoff DC, Al Zahrani WM, Al Saeed AH, Al Dawish MA. Impact of transitioning from conventional blood glucose monitoring to continuous glucose monitoring on glycemic control and self-management in adults with type 2 diabetes on oral glucose-lowering medications. Diabetes Res Clin Pract [Internet]. Elsevier; 2025 [cited 2026 Jan 6]; 229:112458. https:\/\/doi.org\/10.1016\/J.DIABRES.2025.112458.","DOI":"10.1016\/J.DIABRES.2025.112458"},{"key":"1631_CR19","doi-asserted-by":"publisher","unstructured":"Clark TL, Polonsky WH, Soriano EC. The potential impact of continuous glucose monitoring use on diabetes-related attitudes and behaviors in adults with type 2 diabetes: a qualitative investigation of the patient experience. https:\/\/home.liebertpub.com\/dia [Internet]. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA ; 2024 [cited 2026 Jan 8];26:700\u20138. https:\/\/doi.org\/10.1089\/DIA.2023.0612.","DOI":"10.1089\/DIA.2023.0612"},{"key":"1631_CR20","doi-asserted-by":"publisher","unstructured":"GilbertTR, Noar A, Blalock O, Polonsky WH. Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study. https:\/\/home.liebertpub.com\/dia [Internet]. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA ; 2021 [cited 2026 Jan 8];23:S35\u20139. https:\/\/doi.org\/10.1089\/DIA.2020.0666.","DOI":"10.1089\/DIA.2020.0666"},{"key":"1631_CR21","doi-asserted-by":"publisher","unstructured":"Parsons SN, Luzio SD, Dowrick SC, Dunseath GJ, Cheung WY, Gibbs SL, et al. Does the short-term use of continuous glucose monitoring enhance diabetes self-management behaviour in type 2 diabetes? The DISCO GM Study: A randomised, controlled cross-over study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews [Internet]. Elsevier; 2025 [cited 2026 Jan 8];19:103283. https:\/\/doi.org\/10.1016\/J.DSX.2025.103283.","DOI":"10.1016\/J.DSX.2025.103283"},{"key":"1631_CR22","doi-asserted-by":"publisher","unstructured":"Barnard-Kelly KD, Mart\u00ednez-Brocca MA, Glatzer T, Oliver N. Identifying the deficiencies of currently available CGM to improve uptake and benefit. Diabetic Medicine. John Wiley and Sons Inc; 2024;41. https:\/\/doi.org\/10.1111\/DME.15338.","DOI":"10.1111\/DME.15338"},{"key":"1631_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/19322968241276550","volume":"19","author":"K Barnard-Kelly","year":"2025","unstructured":"Barnard-Kelly K, Gonder-Frederick L, Weissberg-Benchell J, Wisk LE. Psychosocial Aspects of Diabetes Technologies: Commentary on the Current Status of the Evidence and Suggestions for Future Directions. J Diabetes Sci Technol [Internet] J Diabetes Sci Technol. 2025;19:27\u201333. https:\/\/doi.org\/10.1177\/19322968241276550. [cited 2025 Nov 20];.","journal-title":"J Diabetes Sci Technol [Internet] J Diabetes Sci Technol"},{"key":"1631_CR24","doi-asserted-by":"publisher","unstructured":"Grammes J, Schmid S, Bozkurt L, Heinemann L, Hess G, Kubiak T et al. Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry. Diabetic Medicine [Internet]. John Wiley and Sons Inc; 2024 [cited 2026 Jan 11];41:e15261. https:\/\/doi.org\/10.1111\/DME.15261;SUBPAGE:STRING:FULL.","DOI":"10.1111\/DME.15261;SUBPAGE:STRING:FULL"},{"key":"1631_CR25","doi-asserted-by":"publisher","unstructured":"Alkabbani W, Cromer SJ, Kim DH, Paik JM, Bykov K, Munshi M, et al. Overall uptake and racial, ethnic, and socioeconomic disparities in the use of continuous glucose monitoring devices among insulin-treated older adults with type 2 diabetes. Diabetes Care [Internet]. American Diabetes Association; 2025 [cited 2026 Jan 11];48:1377\u201385. https:\/\/doi.org\/10.2337\/DCA25-0006.","DOI":"10.2337\/DCA25-0006"},{"key":"1631_CR26","doi-asserted-by":"publisher","unstructured":"Kim H, Yang Y, Ahn J, Kang JH. Acceptability and usability of continuous glucose monitoring systems in older adults aged 75 years and older with diabetes. BMC Geriatrics 2025 25:1 [Internet]. BioMed Central; 2025 [cited 2026 Jan 11];25:1021. https:\/\/doi.org\/10.1186\/S12877-025-06575-4.","DOI":"10.1186\/S12877-025-06575-4"},{"key":"1631_CR27","doi-asserted-by":"publisher","unstructured":"Bao S, Bailey R, Calhoun P, Beck RW. Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin. Diabetes Technol Ther [Internet]. Mary Ann Liebert Inc.; 2022 [cited 2026 Jan 11];24:299\u2013306. https:\/\/doi.org\/10.1089\/DIA.2021.0494\/FORMAT\/EPUB.","DOI":"10.1089\/DIA.2021.0494\/FORMAT\/EPUB"},{"key":"1631_CR28","doi-asserted-by":"publisher","unstructured":"Urbina KL, Slyne C, Munshi MN. Diabetes technology and the older adult: clinical outcomes and implementation strategies. Endocrine Practice [Internet]. Elsevier; 2025 [cited 2026 Jan 11];31:1626\u201331. https:\/\/doi.org\/10.1016\/J.EPRAC.2025.08.004.","DOI":"10.1016\/J.EPRAC.2025.08.004"},{"key":"1631_CR29","doi-asserted-by":"publisher","first-page":"e2445316","DOI":"10.1001\/jamanetworkopen.2024.45316","volume":"7","author":"A Wallia","year":"2024","unstructured":"Wallia A, Agarwal S, Owen AL, Lam EL, Davis K, Bailey SC, et al. Disparities in Continuous Glucose Monitoring Among Patients Receiving Care in Federally Qualified Health Centers. JAMA Netw Open [Internet]. 2024;7:e2445316. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45316.","journal-title":"JAMA Netw Open [Internet]"},{"key":"1631_CR30","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0152","author":"KJ Lipska","year":"2024","unstructured":"Lipska KJ, Oladele C, Zawack K, Gulanski B, Mutalik P, Reaven P, et al. Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy. Diabetes Technol Ther Mary Ann Liebert Inc. 2024. https:\/\/doi.org\/10.1089\/dia.2024.0152.","journal-title":"Diabetes Technol Ther Mary Ann Liebert Inc"},{"key":"1631_CR31","doi-asserted-by":"publisher","first-page":"bvae163810","DOI":"10.1210\/JENDSO\/BVAE163.810","volume":"8","author":"W Solorzano","year":"2024","unstructured":"Solorzano W, Scarlett L, Mangual KPS, Borrell J, Brumley B, Tavares M, et al. Impact of Medicaid Policy Change on CGM Uptake in a Federally Qualified Health Center. J Endocr Soc [Internet] Endocr Soc. 2024;8:bvae163810. https:\/\/doi.org\/10.1210\/JENDSO\/BVAE163.810. [cited 2026 Jan 11];.","journal-title":"J Endocr Soc [Internet] Endocr Soc"},{"key":"1631_CR32","doi-asserted-by":"publisher","unstructured":"Scarlett LD, Solorzano W, Khoshbin K, Villanueva GP, Mangual KS, Tavares M, et al. Impact of a nurse practitioner \u2013 led diabetes program on barriers to CGM use in a federally qualified health center after medicaid expansion. J Diabetes Res. 2025;2025. https:\/\/doi.org\/10.1155\/jdr\/5724236.","DOI":"10.1155\/jdr\/5724236"},{"key":"1631_CR33","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1007\/s11606-023-08222-3","volume":"38","author":"LS Mayberry","year":"2023","unstructured":"Mayberry LS, Guy C, Hendrickson CD, McCoy AB, Elasy T. Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings. J Gen Intern Med [Internet] Springer Int Publishing. 2023;38:2546\u201352. https:\/\/doi.org\/10.1007\/s11606-023-08222-3.","journal-title":"J Gen Intern Med [Internet] Springer Int Publishing"},{"key":"1631_CR34","doi-asserted-by":"publisher","unstructured":"Seidu S, Avery L, Bell H, Brown P, Diggle J, Down S, et al. Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus. Diabetic Medicine. 2024;1\u201313. https:\/\/doi.org\/10.1111\/dme.15500.","DOI":"10.1111\/dme.15500"},{"key":"1631_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3122\/jabfm.2024.240049R1","volume":"37","author":"T Hall","year":"2024","unstructured":"Hall T, Warman MK, Oser T, Filippi MK, Manning B, Carroll JK, et al. Clinician-Reported Barriers and Needs for Implementation of Continuous Glucose Monitoring. J Am Board Fam Med. 2024;37:671\u20139. https:\/\/doi.org\/10.3122\/jabfm.2024.240049R1.","journal-title":"J Am Board Fam Med"},{"key":"1631_CR36","doi-asserted-by":"publisher","unstructured":"Warman M, Fillippi M, Manning B, Oser T, Nease D, Hall T, et al. Continuous glucose monitoring for primary care patients with diabetes: Barriers, facilitators, & resources to support access. Ann Fam Med [Internet]. Ann Fam Med; 2022 [cited 2024 Dec 17];20. https:\/\/doi.org\/10.1370\/AFM.20.S1.268936.","DOI":"10.1370\/AFM.20.S1.268936"},{"key":"1631_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1370\/afm.2876","volume":"20","author":"TK Oser","year":"2022","unstructured":"Oser TK, Hall TL, Dickinson LM, Callen E, Carroll JK, Nease DE, et al. Continuous Glucose Monitoring in Primary Care: Understanding and Supporting Clinicians\u2019 Use to Enhance Diabetes Care. Ann Fam Med Annals Family Med Inc. 2022;20:541\u20137. https:\/\/doi.org\/10.1370\/afm.2876.","journal-title":"Ann Fam Med Annals Family Med Inc"},{"key":"1631_CR38","doi-asserted-by":"publisher","unstructured":"Reaven PD, Macwan S, Newell M, Arani G, Norman GJ, Miller DR, et al. Initiation of continuous glucose monitoring and mortality in type 2 diabetes. https:\/\/home.liebertpub.com\/dia [Internet]. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA ; 2025 [cited 2026 Jan 11]. https:\/\/doi.org\/10.1089\/DIA.2025.0227.","DOI":"10.1089\/DIA.2025.0227"},{"key":"1631_CR39","doi-asserted-by":"publisher","unstructured":"Anagnostopoulou L, Liarakos AL, Ntanasis-Stathopoulos I, Briasoulis A, Tentolouris A. Continuous glucose monitoring and microvascular complications in diabetes: Bridging glycemic metrics with clinical outcomes. Diabetes Obes Metab [Internet]. John Wiley and Sons Inc; 2025 [cited 2026 Jan 11]. https:\/\/doi.org\/10.1111\/DOM.70288;PAGEGROUP:STRING:PUBLICATION.","DOI":"10.1111\/DOM.70288;PAGEGROUP:STRING:PUBLICATION"},{"key":"1631_CR40","doi-asserted-by":"publisher","unstructured":"Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, et al. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care [Internet]. American Diabetes Association; 2020 [cited 2026 Jan 11];43:1146\u201356. https:\/\/doi.org\/10.2337\/DC19-1459.","DOI":"10.2337\/DC19-1459"},{"key":"1631_CR41","doi-asserted-by":"publisher","unstructured":"Frank J, Son D, Szafranski K, Poon Y. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid. 1018553\/jmcp202424025 [Internet]. Academy of Managed Care Pharmacy ; 2024 [cited 2026 Jan 11];30:917\u201328. https:\/\/doi.org\/10.18553\/jmcp202424025.","DOI":"10.18553\/jmcp202424025"},{"key":"1631_CR42","doi-asserted-by":"publisher","unstructured":"Alshannaq H, Matuoka J, Pollock RF, Ahmed W, Lynch P, Norman GJ. Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective. 1018553\/jmcp2025318752 [Internet]. Academy of Managed Care Pharmacy ; 2025 [cited 2026 Jan 11];31:752\u201363. https:\/\/doi.org\/10.18553\/jmcp2025318752.","DOI":"10.18553\/jmcp2025318752"},{"key":"1631_CR43","doi-asserted-by":"publisher","unstructured":"Del Prato S, Giorgino F, Szafranski K, Poon Y. Cost\u2013utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy\u2014An Italian healthcare system perspective. Diabetes Obes Metab [Internet]. John Wiley and Sons Inc; 2024 [cited 2026 Jan 11];26:3633\u201341. https:\/\/doi.org\/10.1111\/DOM.15703;JOURNAL:JOURNAL:14631326;ISSUE:ISSUE:DOI.","DOI":"10.1111\/DOM.15703;JOURNAL:JOURNAL:14631326;ISSUE:ISSUE:DOI"},{"key":"1631_CR44","doi-asserted-by":"publisher","unstructured":"Han G, Zhang X, Ye Y, Wang C, Hu L, Wu H, et al. Cost-effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline HbA1c. Diabetes Obes Metab [Internet]. John Wiley & Sons, Ltd; 2025 [cited 2026 Jan 11]. https:\/\/doi.org\/10.1111\/DOM.70333.","DOI":"10.1111\/DOM.70333"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-026-01631-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-026-01631-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-026-01631-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:51:57Z","timestamp":1782114717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-026-01631-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1631"],"URL":"https:\/\/doi.org\/10.1007\/s11892-026-01631-8","relation":{},"ISSN":["1539-0829"],"issn-type":[{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors were performed in accordance with all applicable ethical standards including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}